ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 130 filers reported holding ARCUS BIOSCIENCES INC in Q3 2020. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $57,000 | -74.4% | 1,861 | -73.2% | 0.00% | – |
| Q4 2020 | $223,000 | +418.6% | 6,953 | +191.5% | 0.00% | – |
| Q3 2020 | $43,000 | -44.9% | 2,385 | -22.2% | 0.00% | – |
| Q2 2020 | $78,000 | +1200.0% | 3,067 | +614.9% | 0.00% | – |
| Q1 2020 | $6,000 | -86.7% | 429 | -90.3% | 0.00% | – |
| Q4 2019 | $45,000 | +55.2% | 4,434 | +39.9% | 0.00% | – |
| Q3 2019 | $29,000 | +38.1% | 3,170 | +18.3% | 0.00% | – |
| Q2 2019 | $21,000 | -86.0% | 2,680 | -77.7% | 0.00% | – |
| Q1 2019 | $150,000 | +2900.0% | 12,002 | +2591.0% | 0.00% | – |
| Q4 2018 | $5,000 | +400.0% | 446 | +596.9% | 0.00% | – |
| Q3 2018 | $1,000 | – | 64 | +73.0% | 0.00% | – |
| Q2 2018 | $0 | – | 37 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |